A new nonrandom unbalanced t(17;20) in myeloid malignancies

World Health Organization Classification of Tumours

CDM Fletcher, Anke van den Berg, Ineke Molenaar · 2002 · 7.1K citations

Medicine, Oncology, Pathology +11

World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

D. K. Hossfeld · Annals of Oncology · 2002 · 4.6K citations · Full text

Veterinary Medicine, Oncology, Pathology +14

The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

David Grimwade, Helen M. Walker, Fiona Oliver et al. · Blood · 1998 · 2.6K citations · Full text

Life Sciences, Hematology, Oncology +12

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor Prognosis

Debes Hammershaimb Christiansen, Mette Klarskov Andersen, J Pedersen-Bjergaard · Journal of Clinical Oncology · 2001 · 303 citations

Life Sciences, Genetics, Hematology +17

Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.

JL Laï, Claude Preudhomme, Marc Zandecki et al. · PubMed · 1995 · 201 citations

Medicine, Hematology, Oncology +15